Monday, July 21, 2014 Headlines about unsettling geopolitical events appear to be weighing on the markets today. But given the …read more

By Jeff Miller To the surprise of many observers, stocks have survived a series of recent challenges. As Q214 earnings …read more

The central banks of the world are massively and insouciantly pursuing financial instability. That’s the inherent result of the 68 …read more

Janet Yellen’s circuitous prattle before the congressional committees this week is a reminder that the Humphrey Hawkins Act is an …read more

Initial claims for unemployment are below bubble record levels after first reaching that extreme in September of last year. The …read more

Buying stocks based on historical low price to sales (P S) ratios has been shown to be an effective investment …read more

Whirlpool Corp. ( WHR ) yesterday completed the first leg of share purchase under the deal signed last week to …read more

Synergy Pharmaceuticals Inc. ( SGYP ) completed patient enrollment for its phase II study on SP 333 being developed for …read more

Salix Pharmaceuticals, Ltd. ( SLXP ) and Pharming Group NV’s Ruconest gained FDA approval for the treatment of acute angioedema …read more